Prothena
Price & Volume
Stats
See moreOpen | $9.19 |
Previous Close | $9.32 |
Day Range | $9.04-$9.56 |
52W Range | $4.32-$20.75 |
Market Cap | $501.6M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $10.3M |
Revenue Growth (YoY) | -96.7% |
Gross Profit (12 Mos) | -$181.8M |
Diluted EPS | -$5.62 |
News
See moreYahoo Finance • last month
Prothena’s SWOT analysis: stock outlook shifts amid pipeline changes
Yahoo Finance • 2 months ago
Novo Nordisk boosts Prothena on plans for amyloidosis therapy
Yahoo Finance • 2 months ago
Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy
Yahoo Finance • 2 months ago
Life360 Reaches Analyst Target Price
About
CEO | Dr. Gene G. Kinney Ph.D. |
CFO | Mr. Tran B. Nguyen M.B.A. |
Address | 77 Sir John Rogerson?s Quay, Dublin, Ireland, D02 VK60 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 163 |
